Nuvation Bio Q3 EPS $(0.12), Inline, Sales $44.951M Beat $34.224M Estimate
Benzinga Newsdesk 1 day ago
NewsEarningsEarnings Beats
Nuvation Bio (NYSE:NUVB) reported quarterly losses of $(0.12) per share which met the analyst consensus estimate. This is a 25 percent increase over losses of $(0.16) per share from the same period last year. The
Nuvation Bio (NYSE:NUVB) reported quarterly losses of $(0.12) per share which met the analyst consensus estimate. This is a 25 percent increase over losses of $(0.16) per share from the same period last year. The company reported quarterly sales of $44.951 million which beat the analyst consensus estimate of $34.224 million by 31.34 percent. This is a 242.61 percent increase over sales of $13.120 million the same period last year.